Gordon Wishart
Professor Gordon C Wishart FRCS FRCS (Eng.) FRCS (Gen.) (3 September 1960-) is the founder, Chief Medical Officer and CEO of Check4Cancer, a leading early cancer detection and cancer prevention company. In 2016 Check4Cancer launched rapid access, streamlined and audited diagnostic pathways for breast and skin cancer to the insured and self-pay markets, leading to the award of “Diagnostic Provider of the Year” at the annual Health Investor Awards in 2018. In late 2017, Check4Cancer launched the first worldwide breast cancer risk test (MyBreastRisk) to combine genetic, family history and lifestyle risk factors to underpin a risk -stratified breast screening programme. As the former Director of the Cambridge Breast Unit from 2005-2010, and current Professor of Cancer Surgery at Anglia Ruskin School of Medicine since 2008, he has a strong track record in clinical research and modernisation of cancer diagnosis and treatment, with more than 100 peer-reviewed papers in scientific journals. In 2010 he led a team of clinicians and scientists that developed the PREDICT breast cancer treatment and survival model, now used worldwide. Early life and education. Gordon Cranston Wishart was born in Edinburgh, Scotland, on 3 September 1960. He studied at the University  of Edinburgh Medical School, where he received his MB ChB in July 1983. He subsequently obtained his MD from the University of Edinburgh in June 1992 with a thesis entitled "Aspects of multidrug resistance in breast cancer". Research and publications. Wishart is notable for his prolific clinical research output, alongside his work as a practising breast and endocrine surgeon. He has published widely and has received numerous prizes for his papers, including Best paper: British Association of Day Surgery 2002; British Journal of Surgery Prize for best paper at British Association of Endocrine Surgeons, September 2006; and British Journal of  Surgery Prize for best paper at British Association of Endocrine Surgeons, September 2007. As of October 2009 he is principal investigator on the following studies: In addition he is co-investigator, surgical coordinator or clinical surgical coordinator on an additional 15 research studies. His research has been published in The Lancet, the British Journal of Cancer, the British Medical Journal, the Journal of Clinical Oncology and the British Journal of Surgery, among others. Current posts. Gordon Wishart currently holds the following posts: He also acts as a referee for the British Journal of Surgery, the European Journal of Surgical Oncology , and Nuclear Medicine Communications.